Cargando…

Cancer-associated retinopathy preceding the diagnosis of cancer

BACKGROUND: The early diagnosis of cancer is of crucial importance and a key prognostic factor. Cancer-associated retinopathy (CAR) can be symptomatic prior to other manifestations directly related to malignant tumors. The aim of this study was to show that, in selected cases, ophthalmic findings ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogewoud, Florence, Butori, Pauline, Blanche, Philippe, Brézin, Antoine P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215635/
https://www.ncbi.nlm.nih.gov/pubmed/30390655
http://dx.doi.org/10.1186/s12886-018-0948-2
_version_ 1783368181259173888
author Hoogewoud, Florence
Butori, Pauline
Blanche, Philippe
Brézin, Antoine P.
author_facet Hoogewoud, Florence
Butori, Pauline
Blanche, Philippe
Brézin, Antoine P.
author_sort Hoogewoud, Florence
collection PubMed
description BACKGROUND: The early diagnosis of cancer is of crucial importance and a key prognostic factor. Cancer-associated retinopathy (CAR) can be symptomatic prior to other manifestations directly related to malignant tumors. The aim of this study was to show that, in selected cases, ophthalmic findings are consistent enough with the diagnosis of CAR to trigger investigations aimed at detecting a previously unknown malignancy. METHODS: This was a monocentric retrospective case series performed in a tertiary referral center. Patients with a diagnosis of CAR were included. Diagnosis was based on the clinical presentation, the visual field and electroretinogram alterations. The clinical presentation, visual field testing and electroretinographic results were analyzed as well as the malignancies identified following the diagnosis of CAR. Follow-up data was collected. RESULTS: Four patients (two men, two women, median age 65.5 years) were included. All patients presented with posterior segment inflammation at initial presentation as well as advanced visual field loss and an extinguished electroretinogram. The best corrected decimal visual acuity was 0.8 or better in both eyes of three patients and decreased to 0.3 OD and O.2 OS in one patient due to a bilateral macular edema. No patient had a previously known history of cancer. Once the diagnosis of CAR was made, investigations aimed at identifying a malignant tumors subsequently led to the diagnosis of two cases of small cell lung tumors, of one prostate carcinoma and of a uterine sarcoma. The treatment of CAR included plasmapheresis, systemic corticosteroids, azathioprine, cyclosporine and periocular or intraocular corticosteroid injections. In all cases the intraocular inflammation resolved, but pigment mottling, diffuse retinal atrophy, optic disc pallor and arterial narrowing were among manifestations observed during the follow-up of the patients. CONCLUSION: In selected patients, findings suggestive of CAR can be useful for the early detection of a cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12886-018-0948-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6215635
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62156352018-11-08 Cancer-associated retinopathy preceding the diagnosis of cancer Hoogewoud, Florence Butori, Pauline Blanche, Philippe Brézin, Antoine P. BMC Ophthalmol Research Article BACKGROUND: The early diagnosis of cancer is of crucial importance and a key prognostic factor. Cancer-associated retinopathy (CAR) can be symptomatic prior to other manifestations directly related to malignant tumors. The aim of this study was to show that, in selected cases, ophthalmic findings are consistent enough with the diagnosis of CAR to trigger investigations aimed at detecting a previously unknown malignancy. METHODS: This was a monocentric retrospective case series performed in a tertiary referral center. Patients with a diagnosis of CAR were included. Diagnosis was based on the clinical presentation, the visual field and electroretinogram alterations. The clinical presentation, visual field testing and electroretinographic results were analyzed as well as the malignancies identified following the diagnosis of CAR. Follow-up data was collected. RESULTS: Four patients (two men, two women, median age 65.5 years) were included. All patients presented with posterior segment inflammation at initial presentation as well as advanced visual field loss and an extinguished electroretinogram. The best corrected decimal visual acuity was 0.8 or better in both eyes of three patients and decreased to 0.3 OD and O.2 OS in one patient due to a bilateral macular edema. No patient had a previously known history of cancer. Once the diagnosis of CAR was made, investigations aimed at identifying a malignant tumors subsequently led to the diagnosis of two cases of small cell lung tumors, of one prostate carcinoma and of a uterine sarcoma. The treatment of CAR included plasmapheresis, systemic corticosteroids, azathioprine, cyclosporine and periocular or intraocular corticosteroid injections. In all cases the intraocular inflammation resolved, but pigment mottling, diffuse retinal atrophy, optic disc pallor and arterial narrowing were among manifestations observed during the follow-up of the patients. CONCLUSION: In selected patients, findings suggestive of CAR can be useful for the early detection of a cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12886-018-0948-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-03 /pmc/articles/PMC6215635/ /pubmed/30390655 http://dx.doi.org/10.1186/s12886-018-0948-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hoogewoud, Florence
Butori, Pauline
Blanche, Philippe
Brézin, Antoine P.
Cancer-associated retinopathy preceding the diagnosis of cancer
title Cancer-associated retinopathy preceding the diagnosis of cancer
title_full Cancer-associated retinopathy preceding the diagnosis of cancer
title_fullStr Cancer-associated retinopathy preceding the diagnosis of cancer
title_full_unstemmed Cancer-associated retinopathy preceding the diagnosis of cancer
title_short Cancer-associated retinopathy preceding the diagnosis of cancer
title_sort cancer-associated retinopathy preceding the diagnosis of cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215635/
https://www.ncbi.nlm.nih.gov/pubmed/30390655
http://dx.doi.org/10.1186/s12886-018-0948-2
work_keys_str_mv AT hoogewoudflorence cancerassociatedretinopathyprecedingthediagnosisofcancer
AT butoripauline cancerassociatedretinopathyprecedingthediagnosisofcancer
AT blanchephilippe cancerassociatedretinopathyprecedingthediagnosisofcancer
AT brezinantoinep cancerassociatedretinopathyprecedingthediagnosisofcancer